2：Multicenter Phase II Study of Whole-Body and Intracranial Activity WithCeritinib in Patients With ALK-Rearranged Non-Small-Cell Lung Cancer PreviouslyTreated With Chemotherapy and Crizotinib: Results From ASCEND-2. J Clin Oncol.2016 Aug 20;34(24):2866-73.
本站仅提供存储服务，所有内容均由用户发布，如发现有害或侵权内容，请
点击举报。
